How big is the Canada In-vitro Diagnostics Market?

The Canada In-vitro Diagnostics Market size is expected to reach USD 3.86 billion in 2024 and grow at a CAGR of 4.98% to reach USD 4.92 billion by 2029. Read More

What is the current Canada In-vitro Diagnostics Market size?

In 2024, the Canada In-vitro Diagnostics Market size is expected to reach USD 3.86 billion. Read More

Who are the key players in Canada In-vitro Diagnostics Market?

Bio-Rad Laboratories Inc., Danaher Corporation, Siemens Healthineers, Abbott Laboratories and Becton, Dickinson and Company are the major companies operating in the Canada In-vitro Diagnostics Market. Read More

What years does this Canada In-vitro Diagnostics Market cover, and what was the market size in 2023?

In 2023, the Canada In-vitro Diagnostics Market size was estimated at USD 3.67 billion. The report covers the Canada In-vitro Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Canada In-vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Canada In-vitro Diagnostics Market Share

Statistics for the 2023 & 2024 Canada In-vitro Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Canada In-vitro Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Canada In-vitro Diagnostics Industry

The Canadian In-Vitro Diagnostics market is moderately competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market. In addition, the rising need for diagnostics due to the rising prevalence of diseases and the advances in IVD is helping a few other smaller players enter the market. Some of the major players in the market are Becton Dickinson and Company, BioMerieux, Bio-Rad Laboratories Inc., Danaher Corporation, and Thermo Fisher Scientific, among others.